Future research should further verify its efficacy and safety in humans, and optimize its formulation and administration methods, providing new options for the treatment of burns, trauma, diabetic ulcers and inflammatory bowel disease
Animal figures dont translate by bodyweight: Multiplying a mouse mg/kg dose by human weight is not how interspecies dosing works, and no properly scaled number would be validated anyway
Yes, many dermatologists recommend combining GHK-Cu with other peptides, NAD+, or retinoids based on personalized skincare objectives
Cagrilintide is investigational only
Your APRN sets the oral dose at intake based on your specific GI indication
If this sounds familiar, you are not alone